PMID: 11325325May 18, 2001Paper

Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence

JAMA : the Journal of the American Medical Association
F StewartJames Trussell

Abstract

Clinical breast and pelvic examinations are commonly accepted practices prior to provision of hormonal contraception. Such examinations, however, may reduce access to highly effective contraceptive methods, and may therefore increase women's overall health risks. These unnecessary requirements also involve ethical considerations and unwittingly reinforce the widely held but incorrect perception that hormonal contraceptive methods are dangerous. This article reviews and summarizes the relevant medical literature and policy statements from major organizations active in the field of contraception. Consensus developed during the last decade supports a change in practice: hormonal contraception can safely be provided based on careful review of medical history and blood pressure measurement. For most women, no further evaluation is necessary. Pelvic and breast examinations and screening for cervical neoplasia and sexually transmitted infection, while important in their own right, do not provide information necessary for identifying women who should avoid hormonal contraceptives or who need further evaluation before making a decision about their use.

Citations

Jul 16, 2014·Clinics in Dermatology·Charlene Lam, Andrea L Zaenglein
Sep 27, 2014·Women's Health·Kathy L MacLaughlinPetra M Casey
May 14, 2003·Journal of Pediatric and Adolescent Gynecology·Elisabeth H Quint
Nov 26, 2009·Obstetrics and Gynecology·Mona SaraiyaShalini Kulasingam
Nov 26, 2010·Obstetrics and Gynecology·Jillian T HendersonCynthia C Harper
Sep 2, 2008·Obstetrics and Gynecology·Paul D Blumenthal, Alison Edelman
Jan 22, 2011·Obstetrics and Gynecology·Zevidah Vickery, Tessa Madden
Feb 5, 2005·Journal of Women's Health·Jacqueline Gardner, Leslie Miller
Feb 2, 2006·American Journal of Public Health·Daniel GrossmanFrancisco T Rivas
Jan 5, 2011·Journal of Women's Health·Carolyn L WesthoffMaryam Guiahi
Apr 2, 2010·Pediatric Rheumatology Online Journal·Melissa S TesherKaren B Onel
Apr 17, 2010·American Journal of Public Health·Joseph E PotterDaniel Grossman
Sep 28, 2002·The Nurse Practitioner·Alison Moriarty Daley, Polly F Cromwell
Jun 9, 2007·The Nurse Practitioner·Joanne Noone
Jul 27, 2004·Current Opinion in Pediatrics·Susan Hayden Gray, Toni Beth Walzer
Feb 24, 2006·Paediatric Drugs·Rollyn M Ornstein, Martin M Fisher
Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Feb 27, 2003·Journal of Pediatric and Adolescent Gynecology·Elisabeth H Quint
Nov 7, 2003·The New England Journal of Medicine·Carolyn Westhoff
Nov 10, 2015·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Sally RafieCynthia C Harper
Feb 26, 2009·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Tuire Sannisto, Elise Kosunen
Apr 13, 2012·Expert Opinion on Investigational Drugs·Anita L Nelson
Apr 25, 2012·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Laura ArmstrongHind A Beydoun
Feb 22, 2016·Journal of the American Academy of Dermatology·Andrea L ZaengleinKevin M Boyer
Feb 7, 2009·Journal of the American Pharmacists Association : JAPhA·Sharon LandauDiana Greene Foster
Nov 10, 2011·Journal of the American Pharmacists Association : JAPhA·Sally Rafie, Shareen Y El-Ibiary
Mar 25, 2008·Journal of the American Pharmacists Association : JAPhA·Jacqueline S GardnerSolmaz Shotorbani
Sep 14, 2010·Journal of the American Pharmacists Association : JAPhA·Karen B FarrisOrod Solemani
Jan 11, 2013·Journal of Pediatric and Adolescent Gynecology·Kathleen Morrell
Nov 6, 2012·Contraception·Naomi K TepperPolly A Marchbanks
Jun 11, 2015·Nursing for Women's Health·Elizabeth GabzdylBarbara L McFarlin
Aug 9, 2003·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Debbie Postlethwaite
Apr 4, 2009·Contraception·Suzan GoodmanJ Joseph Spiedel
Dec 17, 2015·Journal of Women's Health·Kate Grindlay, Daniel Grossman
Dec 2, 2008·Contraception·Rameet SinghElisa Wells
Mar 25, 2008·Journal of the American Academy of Dermatology·Jason E FrangosAlexa B Kimball
May 3, 2007·Obstetrics and Gynecology Clinics of North America·Lawrence Leeman
May 23, 2006·Primary Care·Elizabeth Feldman
Jul 15, 2015·Journal of General Internal Medicine·Jennifer PotterDana J Pardee
Oct 23, 2009·Dermatologic Therapy·Julie C Harper
Nov 22, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Christos C Zouboulis
Sep 28, 2006·Studies in Family Planning·Sara E YeatmanDaniel A Grossman
Feb 20, 2007·Annals of the New York Academy of Sciences·Efthimios DeligeoroglouGeorge Creatsas
Jun 12, 2012·Perspectives on Sexual and Reproductive Health·Amanda Dennis, Daniel Grossman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved